REBEKAH CASHIN: Open Payments
NPI 1982723474 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 40 payments from 10 companies in 2025. Trend: 2023 $75 · 2024 $793 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 12 | $299 |
| Lilly USA, LLC | 6 | $230 |
| ARGENX US, INC. | 7 | $202 |
| ABBVIE INC. | 4 | $82 |
| Lundbeck LLC | 4 | $79 |
| ACADIA Pharmaceuticals Inc | 2 | $53 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $36 |
| UCB, Inc. | 1 | $35 |
| PFIZER INC. | 1 | $29 |
| Boston Scientific Corporation | 1 | $24 |
Products named: Leqembi, VYVGART HYTRULO, KISUNLA, AMYVID, VYEPTI, UBRELVY, NUPLAZID, FIRDAPSE.
Industry payments across TN — which companies pay providers there.
